News
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback